#BenchToBedside: Advances in CAR T-Cell Therapy for Solid Tumor Treatment

CAR T-cell therapy is one of immunotherapy’s most exciting developing cancer treatments. FDA-approved for several blood cancer types, CAR T is now being studied to treat solid tumors. Joseph McGuirk, division director of hematologic malignancies and a leader in field, is in the studio to share the latest updates.

Видео #BenchToBedside: Advances in CAR T-Cell Therapy for Solid Tumor Treatment канала The University of Kansas Cancer Center